Regulus Therapeutics (RGLS US)

Regulus Therapeutics Inc. operates within the biopharmaceutical industry. The Company's products aim to treat and prevent hepatitis C infections, cardiovascular, fibrosis, oncology, immuno-inflammatory, and metabolic diseases. Regulas Therapeutics offers its services worldwide.